AUPN079195A0 - Expression system and method for inhibiting replication of human immunodeficiency virus (hiv) - Google Patents

Expression system and method for inhibiting replication of human immunodeficiency virus (hiv)

Info

Publication number
AUPN079195A0
AUPN079195A0 AUPN0791A AUPN079195A AUPN079195A0 AU PN079195 A0 AUPN079195 A0 AU PN079195A0 AU PN0791 A AUPN0791 A AU PN0791A AU PN079195 A AUPN079195 A AU PN079195A AU PN079195 A0 AUPN079195 A0 AU PN079195A0
Authority
AU
Australia
Prior art keywords
hiv
expression system
immunodeficiency virus
human immunodeficiency
inhibiting replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN0791A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Priority to AUPN0791A priority Critical patent/AUPN079195A0/en
Publication of AUPN079195A0 publication Critical patent/AUPN079195A0/en
Priority to PCT/AU1996/000041 priority patent/WO1996023876A1/en
Priority to AU44760/96A priority patent/AU4476096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AUPN0791A 1995-01-30 1995-01-30 Expression system and method for inhibiting replication of human immunodeficiency virus (hiv) Abandoned AUPN079195A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPN0791A AUPN079195A0 (en) 1995-01-30 1995-01-30 Expression system and method for inhibiting replication of human immunodeficiency virus (hiv)
PCT/AU1996/000041 WO1996023876A1 (en) 1995-01-30 1996-01-29 Expression system and method for inhibiting replication of human immunodeficiency virus (hiv)
AU44760/96A AU4476096A (en) 1995-01-30 1996-01-29 Expression system and method for inhibiting replication of human immunodeficiency virus (hiv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN0791A AUPN079195A0 (en) 1995-01-30 1995-01-30 Expression system and method for inhibiting replication of human immunodeficiency virus (hiv)

Publications (1)

Publication Number Publication Date
AUPN079195A0 true AUPN079195A0 (en) 1995-02-23

Family

ID=3785151

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN0791A Abandoned AUPN079195A0 (en) 1995-01-30 1995-01-30 Expression system and method for inhibiting replication of human immunodeficiency virus (hiv)

Country Status (2)

Country Link
AU (1) AUPN079195A0 (en)
WO (1) WO1996023876A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression

Also Published As

Publication number Publication date
WO1996023876A1 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
AU5585094A (en) Blood product disposal system and method
AU6479696A (en) Antisense inhibition of hepatitis b virus replication
AU3358895A (en) Achromatic optical system including diffractive optical element, and method of forming same
AU4750390A (en) Virus inactivated blood product and method
AU1566595A (en) Method and reagent for inhibiting hepatitis c virus replication
AU8119794A (en) Method and means for prevention of cataract
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
AU6774294A (en) Methods of preventing viral replication
PL312353A1 (en) 2-(2-n-alkoxyphenyl) purin-6-ones, method of obtaining and drugs containing them
AU5848794A (en) Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
AU1192892A (en) Pharmaceutical preparation of antistress, stress-preventive and nootropic action
AU3135093A (en) Connection-type treatment system for micro solution and method of treatment
EP0844850A4 (en) System for controlling the spread of hiv/aids and other infectious diseases
AU7465696A (en) Synthetic vaccine for protection against human immunodeficiency virus infection
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
AU6962894A (en) Compositions and methods for inhibiting replication of human immunodeficiency virus-1
AU4602897A (en) Method for treatment of immunodeficiency virus infection
AU7212694A (en) Inhibition of human immunodeficiency virus reproduction by deoxyribonuclease i
AU4767896A (en) Human immunodeficiency virus transcription inhibitors and methods of their use
AUPN079195A0 (en) Expression system and method for inhibiting replication of human immunodeficiency virus (hiv)
AUPN541095A0 (en) A method and system of processing waste
AU7192394A (en) Production method for preparation of disabled viruses
AU6378598A (en) Method for inhibition of virus replication
AU4476096A (en) Expression system and method for inhibiting replication of human immunodeficiency virus (hiv)
AU7618296A (en) Method of creating message connections for group and/or multiaddress calling